DIAGNOSYS LLC

Diagnosys LLC is a specialized manufacturer of visual electrophysiology test systems for both preclinical research and clinical ophthalmology practice. With over 40 years of market presence, the company designs and manufactures hardware and software for measuring visual function through electroretinography (ERG), pattern electroretinography (PERG), visually evoked potentials (VEP), and related electrophysiological testing modalities. The company's product portfolio spans three major categories: (1) Preclinical systems, including the proprietary Celeris® platform for rodent testing with dual-function stimulator-electrodes and ERG solutions for small to large animals; (2) Clinical visual function test systems encompassing visual electrophysiology, visual psychophysical testing, objective acuity measurement, and pupillometry; and (3) Trial services including study setup assistance, operator training, and quality assurance data review for multi-site clinical research. Diagnosys serves a global customer base that includes leading academic medical centers, eye institutes, and specialty ophthalmology practices such as Mayo Clinic, Bascom Palmer Eye Institute, Cleveland Clinic, Moorfields Eye Hospital, and Wilmer Eye Institute. The systems are used across multiple ophthalmology subspecialties: retina (inherited retinal diseases), glaucoma, pediatric ophthalmology, and neuro-ophthalmology. The company also actively supports clinical trial infrastructure with 35+ years of trial services experience. Key capabilities include in-house hardware and software design, patented and trademarked platforms, and extensive clinical validation across academic and research institutions worldwide. The company participates in major scientific conferences (ARVO, Society for Neuroscience) and provides continuing education webinars on visual electrophysiology methodology.